title: [Clinical picture and diagnostic criteria of multiple system atrophy].
abstract: In 2013, European MSA Study Group demonstrated the prospective natural history of MSA. This study was greatly useful for better patients' management and future development of disease-modifying therapy. Although the diagnosis of early symptomatic stage is also an important factor for successful outcome of disease-modifying therapy, current diagnostic criteria for MSA, which has focused on the combination of motor and autonomic manifestations cannot diagnose MSA patients showing isolated autonomic failure in the early course of illness. We presented four premotor MSA patients who had sudden death prior to fulfilling the diagnostic criteria. 4 cases had very mild OPC and SN pathology, but significant autonomic system involvement including the intermediolateral nucleus, Onuf's nucleus, and medullary autonomic nucleus. Contrary, Petrovic et al reported four pathologically proven MSA patients with disease duration of 15 years or more. All patients presented isolated parkinsonism for a long time and mean duration from onset to dysautonomia was 9 years. Novel diagnostic biomarkers, which have a potential for evaluation of the component of glial cytoplasmic inclusion such as alpha-synuclein radiotracer and serum and CSF alpha-synuclein levels may be a key way to support the diagnosis of patients at the stage of "mono system atrophy".
authors: Brain and Mind Research Center, Nagoya Univeristy.
authors: Hirohisa
authors: H
authors: Watanabe
authors: Mari
authors: M
authors: Yoshida
authors: Gen
authors: G
authors: Sobue
mesh_terms: D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D003645:Death, Sudden / Q000209:etiology; D054439:Ghrelin / Q000097:blood; D006801:Humans; D019578:Multiple System Atrophy / Q000150:complications / Q000175:diagnosis* / Q000473:pathology*; D020734:Parkinsonian Disorders / Q000209:etiology; D013997:Time Factors; D051844:alpha-Synuclein / Q000097:blood / Q000134:cerebrospinal fluid
chemical_list: D015415:Biomarkers; D054439:Ghrelin; D051844:alpha-Synuclein